Radiology Imaging

The radiology imaging channel includes technology news related to computed tomography (CT), digital radiography (DR / X-ray), ultrasound, magnetic resonance imaging (MRI), radiographic fluoroscopy (R/F), mammography, angiography, 3-D printing, contrast media injectors, molecular imaging, neurological imaging, pediatric imaging and radiation dose management. 

Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’ AI solutions to patients and medical professionals worldwide
News | Breast Imaging
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time May 28, 2024
arrow
A recently-published study, found that in individuals with a history of smoking, progression of quantitative interstitial abnormalities (QIA) at CT was associated with severe acute respiratory events, independent of comorbidities, such as emphysema and small airway disease.
News | Lung Imaging
Lung Abnormality Progression Linked to Acute Respiratory Disease in Smokers

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic, Inc. BioZorb marker due to complications with implanted devices.
News | FDA
Hologic, Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
Medtronic has reported preliminary findings of the first and only head-to-head trial comparing standard-of-care CT-guided biopsy with electromagnetic navigation bronchoscopy (ENB) for the diagnosis of lung nodules.
News | Radiology Business
Medtronic Announces Positive Preliminary Data from VERITAS Clinical Study at American Thoracic Society, ATS 2024

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
Brandon Suh, CEO of Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of its acquisition of Volpara Health Technologies, a global developer of medical software for breast cancer screening.
News | Artificial Intelligence
Lunit Announces Completion of Volpara Acquisition to Advance AI-driven Cancer Care

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
RBfracture
News | Artificial Intelligence
Lunit Partners with Radiobotics to Enhance Diagnostic Synergies in AI Medical Imaging

May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...

Time May 22, 2024
arrow
According to a newly-published study of nearly 5,000 screening mammograms interpreted by an FDA-approved AI algorithm, patient characteristics such as race and age influenced false positive results.
News | Artificial Intelligence
New Study Finds Age and Race Impact Artificial Intelligence (AI) Performance on Digital Mammograms

May 21, 2024 — According to a newly-published study of nearly 5,000 screening mammograms interpreted by an FDA-approved ...

Time May 21, 2024
arrow
Proteus ONE compact proton therapy system
News | Proton Therapy
IBA signs contract with Yale New Haven Health and Hartford HealthCare to Install Proteus ONE Proton Therapy Solution

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
New Exo Works tailored package allows POCUS clinical and educational programs to get up and running with minimal IT effort
News | Point-of-Care Ultrasound (POCUS)
Exo Introduces Exo Works Connect to Deploy POCUS Programs in Days

May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo ...

Time May 20, 2024
arrow
Registration is now open for #ASTRO24
News | ASTRO
American Society for Radiation Oncology (ASTRO) to Host Annual Meeting in Washington, DC, Sept. 29-Oct. 2

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
Dice similarity index—comparison of x-ray pulsatility index to digital subtraction angiography
News | Cardiac Imaging
Noncontrast Fluoroscopy vs. Pulmonary Angiography for Blood Flow Evaluation

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
AI is applied to CT scans to automatically segment different heart chambers and quantify arterial plaque
News | Artificial Intelligence
Using AI to Repurpose Routine CT Scans

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
Ground-truth manual organ segmentations (yellow) vs. DynUNet-TL (green) and TotalSegmentator (red) predictions
News | Pediatric Imaging
DL Development, Validation for Abdominal CT Organ Segmentation in Children

May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...

Time May 15, 2024
arrow
New 10-year strategic agreement builds on 40-year collaboration history
News | Radiology Business
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
A new UCLA study found Unfold AI’s precise prediction of prostate margins significantly impacts the success of focal therapy treatments
News | Prostate Cancer
New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
Prospective pilot research study is first of its kind to attempt to quantify the impact of playing, training, and rest over a professional basketball season on musculoskeletal health with a cohort of elite professional basketball players from multiple teams
News | Radiology Imaging
NBA, NBPA, and NGBPU Collaborate with GE HealthCare and MedStar Health on Musculoskeletal and Joint Health Study

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
A, Normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with BM = 43.2. B, Fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in 52-year-old woman with BMI = 45.8.
News | Breast Imaging
Enlarged Lymph Nodes on Screening Mammograms Predict Cardiometabolic Disease, Cardiovascular Risk

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients receiving care at accredited cancer hospitals in Pennsylvania
News | Radiation Oncology
Affordable Care Act Expansions Improved Access to Cancer Care, Study Suggests

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
Swedish biotech company Ascelia Pharma has announced its liver imaging drug candidate, Orviglance, significantly improved visualization of focal liver lesions, having successfully met the primary endpoint in the pivotal Phase 3 study, SPARKLE. CEO Magnus Corftizen shown here, offered an update on the first-in-class contrast agent for use in liver MRI in patients with severely impaired kidney function which has been granted FDA Orphan Drug Designation.
News | Contrast Media
Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now